189 related articles for article (PubMed ID: 16007190)
1. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.
Lucas B; Grigo K; Erdmann S; Lausen J; Klein-Hitpass L; Ryffel GU
Oncogene; 2005 Sep; 24(42):6418-31. PubMed ID: 16007190
[TBL] [Abstract][Full Text] [Related]
2. Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line.
Thomas H; Senkel S; Erdmann S; Arndt T; Turan G; Klein-Hitpass L; Ryffel GU
Nucleic Acids Res; 2004 Nov; 32(19):e150. PubMed ID: 15520459
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
4. HNF4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells.
Grigo K; Wirsing A; Lucas B; Klein-Hitpass L; Ryffel GU
Biol Chem; 2008 Feb; 389(2):179-87. PubMed ID: 18163890
[TBL] [Abstract][Full Text] [Related]
5. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific transcription factor HNF4alpha inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 beta-cell line.
Erdmann S; Senkel S; Arndt T; Lucas B; Lausen J; Klein-Hitpass L; Ryffel GU; Thomas H
Biol Chem; 2007 Jan; 388(1):91-106. PubMed ID: 17214554
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
11. Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
Anastasiadis AG; Lemm I; Radzewitz A; Lingott A; Ebert T; Ackermann R; Ryffel GU; Schulz WA
Anticancer Res; 1999; 19(3A):2105-10. PubMed ID: 10470156
[TBL] [Abstract][Full Text] [Related]
12. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer.
Rennel E; Mellberg S; Dimberg A; Petersson L; Botling J; Ameur A; Westholm JO; Komorowski J; Lassalle P; Cross MJ; Gerwins P
Exp Cell Res; 2007 Apr; 313(7):1285-94. PubMed ID: 17362927
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.
Jöhrer K; Zelle-Rieser C; Perathoner A; Moser P; Hager M; Ramoner R; Gander H; Höltl L; Bartsch G; Greil R; Thurnher M
Clin Cancer Res; 2005 Apr; 11(7):2459-65. PubMed ID: 15814620
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma related novel gene, GYLZ-RCC18: cloning and functional studies.
Zhang Q; Chen L; Liang L; Xi Z; Ding Y; Tong M; Zhang Z; Lee C; Guo Y
Chin Med J (Engl); 2002 May; 115(5):746-9. PubMed ID: 12133548
[TBL] [Abstract][Full Text] [Related]
15. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
[TBL] [Abstract][Full Text] [Related]
16. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
17. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
Gnarra JR; Dressler GR
Cancer Res; 1995 Sep; 55(18):4092-8. PubMed ID: 7664285
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells.
Ami Y; Shimazui T; Akaza H; Uematsu N; Yano Y; Tsujimoto G; Uchida K
Oncol Rep; 2005 Jan; 13(1):75-80. PubMed ID: 15583805
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-type.
Sen B; Wolf DC; Hester SD
Mutat Res; 2004 May; 549(1-2):213-24. PubMed ID: 15120972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
